- Home
- HIFS vs TSHA Comparison
HIFS vs TSHA Comparison
Compare HIFS & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIFS
- TSHA
- Stock Information
- Founded
- HIFS 1834
- TSHA 2019
- Country
- HIFS United States
- TSHA United States
- Employees
- HIFS N/A
- TSHA N/A
- Industry
- HIFS Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- HIFS Finance
- TSHA Health Care
- Exchange
- HIFS Nasdaq
- TSHA Nasdaq
- Market Cap
- HIFS 485.3M
- TSHA 397.8M
- IPO Year
- HIFS N/A
- TSHA 2020
- Fundamental
- Price
- HIFS $262.50
- TSHA $2.34
- Analyst Decision
- HIFS
- TSHA Strong Buy
- Analyst Count
- HIFS 0
- TSHA 8
- Target Price
- HIFS N/A
- TSHA $6.63
- AVG Volume (30 Days)
- HIFS 15.3K
- TSHA 3.3M
- Earning Date
- HIFS 04-11-2025
- TSHA 05-15-2025
- Dividend Yield
- HIFS 0.96%
- TSHA N/A
- EPS Growth
- HIFS 14.93
- TSHA N/A
- EPS
- HIFS 12.96
- TSHA N/A
- Revenue
- HIFS $67,590,000.00
- TSHA $8,333,000.00
- Revenue This Year
- HIFS N/A
- TSHA N/A
- Revenue Next Year
- HIFS N/A
- TSHA N/A
- P/E Ratio
- HIFS $20.37
- TSHA N/A
- Revenue Growth
- HIFS 12.43
- TSHA N/A
- 52 Week Low
- HIFS $164.00
- TSHA $1.05
- 52 Week High
- HIFS $300.00
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- HIFS 62.97
- TSHA 63.23
- Support Level
- HIFS $250.58
- TSHA $1.85
- Resistance Level
- HIFS $273.50
- TSHA $2.28
- Average True Range (ATR)
- HIFS 5.09
- TSHA 0.25
- MACD
- HIFS 1.43
- TSHA 0.03
- Stochastic Oscillator
- HIFS 67.16
- TSHA 62.44
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.